Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Repligen Corporation to Present at Upcoming May Investor Conferences
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences
-
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event
-
Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
-
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
-
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
-
Hillman Reports First Quarter 2024 Results
-
Enable Injections Expands Strategic Partnership with Roche
-
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
-
Calvetti Ferguson Supports Firm Growth in Nashville with New Business Development Officer and Tax Director
-
iSpecimen Reports First Quarter 2024 Results
-
Arbutus to Participate in Two Upcoming Investor Conferences
-
Form 8.3 - Centaur Media PLC
-
Managers’ transactions
-
Prosafe SE: Annual General Meeting completed
-
In light of discussions on financial statement
-
Avance Gas agrees one-year Time Charter for Chinook
-
Draganfly Unveils New NDAA Compliant “FlexForce” Modular FPV System Following US Military Demonstrations & Training
-
Draganfly Unveils New NDAA Compliant “FlexForce” Modular FPV System Following US Military Demonstrations & Training
-
Crane NXT Completes Acquisition of OpSec Security
-
Tellabs Evolves Modern Enterprise Networking with In-Wall FlexSym ONT203W for fiber-based Passive Optical Networks
-
The Joint Corp. to Participate in Upcoming Investor Conferences
-
uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
-
Apellis Pharmaceuticals Reports First Quarter 2024 Financial Results
-
SES’s O3b mPOWER System Launches Service via Gilat’s SkyEdge IV Platform
-
INE Wins Four Cybersecurity Awards in 12th Annual Global InfoSec Awards at #RSAC 2024
-
Angus Gold Makes New High-Grade Gold Discovery West of Historic Dorset Resource Area, Intersects 7.0 g/t Au Over 12.4 Metres, including 21.7g/t Au Over 3.3 Metres
-
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results
-
Ascot Announces C$5.0 Million Non-Brokered Flow Through Private Placement
-
BioCryst to Present at Upcoming Investor Conferences
-
Meritage Homes Announces Pricing of Convertible Senior Notes
-
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
-
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
West Red Lake Gold Intersects 21.33 g/t Au over 3.1m and 6.75 g/t Au over 9m at South Austin Zone – Madsen Mine
-
NioBay Confirms Phosphate in Historic Vior Drill Holes on Foothills Property
-
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results
-
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
-
Casino Time Elevates Social Gaming in Ontario with Launch of iGaming Website
-
GlobalFoundries Reports First Quarter 2024 Financial Results
-
Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now
-
Lightbend Adds Industry Veteran Dan Rosanova as Head Of Product
-
FibroGen to Participate in Upcoming Investor Conferences
-
Bioventus Reports First Quarter Financial Results
-
Think Power Solutions Continues to Excel as a Great Place to Work-Certified™ for Fourth Consecutive Year
-
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
-
Eli Electric Vehicles Opens Reservations for its Highly Anticipated Eli ZERO Micro-EV in the US
